Ketazolam (CAS 27223-35-4): Basic Information and Properties

Ketazolam is a benzodiazepine derivative with anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant properties. It is used for the treatment of anxiety and has similar effectiveness compared to diazepam. Ketazolam appears to produce reduced levels of side effects such as sedation compared with diazepam.

Ketazolam is available in various countries under different brand names, including Anseren, Ansieten, Ansietil, Marcen, Sedatival, Sedotime, Solatran, and Unakalm. However, it is not approved for sale in Norway, Australia, United Kingdom, or the United States.

Frequently Asked Questions about Ketazolam

Q: What are the main therapeutic uses of Ketazolam?

A: Ketazolam is primarily used for the treatment of anxiety. It is also an effective antispasmodic drug and is used for the treatment of spasticity.

Q: Are there any concerns regarding tolerance and dependence with Ketazolam use?

A: Yes, chronic use of ketazolam, like other ***, can lead to physical dependence and the appearance of benzodiazepine withdrawal syndrome upon cessation of use or decrease in dose. Tolerance to ketazolam's therapeutic effects occurs over a period of 15 days.

Q: What precautions should be taken when using Ketazolam?

A: Benzodiazepines, including ketazolam, require special precaution if used in the elderly, during pregnancy, in children, alcohol or drug-dependent individuals, and individuals with comorbid psychiatric disorders.

Q: What is the legal status of Ketazolam?

A: Ketazolam is a List 3 drug under the Betäubungsmittelgesetz in Germany, a List II drug of the Opium Law in the Netherlands, and a Schedule IV drug under the Controlled Substances Act in the US.